Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * |
Title | HemoShear - Discovering New Treatments For Metabolic Disorders | HemoShear |
Description | New Insights. New HemoShear is discovering new treatments for rare metabolic disorders. We also partner with biopharma companies to accelerate their drug |
Keywords | N/A |
WebSite | hemoshear.com |
Host IP | 208.75.148.200 |
Location | United States |
Site | Rank |
US$6,121,244
Last updated: 2023-04-29 09:12:48
hemoshear.com has Semrush global rank of 1,729,110. hemoshear.com has an estimated worth of US$ 6,121,244, based on its estimated Ads revenue. hemoshear.com receives approximately 706,298 unique visitors each day. Its web server is located in United States, with IP address 208.75.148.200. According to SiteAdvisor, hemoshear.com is safe to visit. |
Purchase/Sale Value | US$6,121,244 |
Daily Ads Revenue | US$5,651 |
Monthly Ads Revenue | US$169,512 |
Yearly Ads Revenue | US$2,034,137 |
Daily Unique Visitors | 47,087 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
hemoshear.com. | A | 7199 | IP: 208.75.148.200 |
hemoshear.com. | NS | 43200 | NS Record: ns1.mytechtailor.com. |
hemoshear.com. | NS | 43200 | NS Record: ns2.mytechtailor.com. |
hemoshear.com. | MX | 43200 | MX Record: 10 alt3.aspmx.l.google.com. |
hemoshear.com. | MX | 43200 | MX Record: 10 alt4.aspmx.l.google.com. |
hemoshear.com. | MX | 43200 | MX Record: 1 aspmx.l.google.com. |
hemoshear.com. | MX | 43200 | MX Record: 5 alt1.aspmx.l.google.com. |
hemoshear.com. | MX | 43200 | MX Record: 5 alt2.aspmx.l.google.com. |
hemoshear.com. | TXT | 43200 | TXT Record: v=spf1 +a +mx +ip4:208.75.148.200 +include:_spf.google.com ~all |
Company HST5040 Patients Pipeline Platform News Careers New Insights. New Hope. HemoShear Therapeutics is a clinical stage company developing novel treatments for patients with rare diseases. We are implementing a new vision for how advanced biological and computational models can accelerate the discovery of innovative therapies to change the course of disease. News: Brian Wamhoff, PhD named interim CEO Read More » Developing Treatments for Rare Diseases Using our powerful REVEAL-Tx TM drug discovery platform, our scientists are identifying and validating promising approaches to develop novel treatments aiming to extend and improve the quality of life of patients with rare diseases. In our most advanced program, the company is conducting a phase 2 clinical trial of HST5040, an oral small molecule investigational drug for the treatment of patients with methylmalonic acidemia (MMA) and propionic acidemia (PA). These genetic disorders are caused by deficiencies of certain metabolic |
HTTP/1.1 301 Moved Permanently Date: Fri, 22 Oct 2021 08:18:36 GMT Server: Apache Location: https://hemoshear.com/ Cache-Control: max-age=0 Expires: Fri, 22 Oct 2021 08:18:36 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 x-frame-options: deny x-xss-protection: 1; mode=block x-content-type-options: nosniff cache-control: max-age=0 expires: Fri, 22 Oct 2021 08:18:37 GMT x-content-type-options: nosniff content-type: text/html; charset=UTF-8 date: Fri, 22 Oct 2021 08:18:37 GMT server: Apache |
Domain Name: HEMOSHEAR.COM Registry Domain ID: 1386690815_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2020-01-14T19:59:53Z Creation Date: 2008-01-24T14:01:06Z Registry Expiry Date: 2023-01-24T14:01:06Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.MYTECHTAILOR.COM Name Server: NS2.MYTECHTAILOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T23:55:23Z <<< |